List of SBIR/STTR awards granted to Amplyx Pharmaceuticals
Amplyx PharmaceuticalsName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Amplyx Pharmaceuticals in August, 2017 for $1,475,794.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AI131864-01A1 | Phase II | 1,475,794 | August 18, 2017 | |||||||
A SBIR Phase II contract was awarded to Amplyx Pharmaceuticals in July, 2015 for $1,495,390.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI106235-03 | Phase II | 1,495,390 | July 1, 2015 | |||||||
A SBIR Phase II contract was awarded to Amplyx Pharmaceuticals in July, 2016 for $1,460,969.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AI125017-01 | Phase II | 1,460,969 | July 1, 2016 | |||||||
A SBIR Phase II contract was awarded to Amplyx Pharmaceuticals in June, 2014 for $1,499,263.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI096844-02A1 | Phase II | 1,499,263 | June 1, 2014 | |||||||
A SBIR Phase II contract was awarded to Amplyx Pharmaceuticals in August, 2014 for $1,499,498.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44NS079204-03A1 | Phase II | 1,499,498 | August 1, 2014 | |||||||
A SBIR Phase I contract was awarded to Amplyx Pharmaceuticals for $225,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI112467-01 | Phase I | 225,000 | ||||||||
A SBIR Phase I contract was awarded to Amplyx Pharmaceuticals for $599,104.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI106235-01 | Phase I | 599,104 | ||||||||
A SBIR Phase I contract was awarded to Amplyx Pharmaceuticals for $300,959.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43TR000354-01A1 | Phase I | 300,959 | ||||||||
A SBIR Phase I contract was awarded to Amplyx Pharmaceuticals for $696,719.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS083413-01 | Phase I | 696,719 | ||||||||
A SBIR Phase I contract was awarded to Amplyx Pharmaceuticals for $697,056.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS079204-01A1 | Phase I | 697,056 | ||||||||
A SBIR Phase I contract was awarded to Amplyx Pharmaceuticals for $580,422.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI098636-01 | Phase I | 580,422 | ||||||||
A SBIR Phase I contract was awarded to Amplyx Pharmaceuticals for $558,144.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI098300-01A1 | Phase I | 558,144 | ||||||||
A SBIR Phase I contract was awarded to Amplyx Pharmaceuticals for $300,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI096844-01 | Phase I | 300,000 |
